University of Colorado Anschutz Medical Campus, Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, Aurora, Colorado, and Denver Veterans Affairs Medical Center, Denver, Colorado 80045, USA.
Am J Cardiol. 2012 Nov 6;110(9 Suppl):58B-68B. doi: 10.1016/j.amjcard.2012.08.036.
Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including CAD, stroke, peripheral vascular disease, and other vascular disease. While glycemic management remains a cornerstone of DM care, the co-management of hypertension, atherosclerosis, cardiovascular risk reduction, and prevention of long-term consequences associated with DM are now well recognized as essential to improve long-term survival. Clinical trial evidence substantiates the importance of glycemic control, low-density cholesterol-lowering therapy, blood pressure lowering, control of albuminuria, and comprehensive approaches targeting multiple risk factors to reduce cardiovascular risk. This article presents a review of the role of DM in the pathogenesis of atherosclerosis and cardiac dysfunction, recent evidence on the degree of glycemic control and mortality, and available evidence for a multifaceted approach to improve long-term outcomes for patients.
糖尿病(DM)是全球第五大死亡原因,也是导致癌症和心血管疾病(包括 CAD、中风、外周血管疾病和其他血管疾病)等主要死亡原因的因素之一。尽管血糖管理仍然是 DM 护理的基石,但高血压、动脉粥样硬化、降低心血管风险以及预防与 DM 相关的长期后果的共同管理,现在已被公认为改善长期生存的关键。临床试验证据证实了血糖控制、降低低密度胆固醇、降低血压、控制蛋白尿以及针对多种危险因素的综合方法对于降低心血管风险的重要性。本文回顾了 DM 在动脉粥样硬化和心脏功能障碍发病机制中的作用、近期关于血糖控制程度和死亡率的证据,以及改善患者长期预后的多方面方法的现有证据。